newsfilter
← Latest News
GlobeNewswire·

Otonomy Announces OTO-413 Presentations at American Auditory Society Annual Meeting

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced two upcoming presentations on the OTO-413 hearing loss pro